A Multinational, Multicenter, Randomized, Double-blind, Vehicle-controlled, Parallel-group Comparison Trial to Demonstrate the Superiority of 1% OPA-15406 Ointment to the Vehicle in Adult Patients with Atopic Dermatitis
Latest Information Update: 28 Mar 2025
At a glance
- Drugs Difamilast (Primary)
- Indications Atopic dermatitis
- Focus Registrational; Therapeutic Use
- Sponsors Otsuka Beijing Research Institute
Most Recent Events
- 25 Mar 2025 Status changed from recruiting to completed.
- 08 Apr 2024 Planned End Date changed from 1 Mar 2024 to 31 Jan 2025.
- 08 Apr 2024 Planned primary completion date changed from 30 Dec 2023 to 31 Jul 2024.